Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality.

By T. King, M. Schwarz, K. Brown, Janet Tooze, T. Colby, J. Waldron, A. Flint, W. Thurlbeck, R. Cherniack. American Journal of Respiratory and Critical Care Medicine, 2001

635 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/da96b54b55919b3011bce0d0d279859ae92d65e6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. H. Collard
2. T. King
3. B. Ley
4. R. Mason
5. Zhi Zhang
6. T. Kamimura
7. H. Kasai
8. Jeremy T. Allen

Citations in the corpus

• Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. (2005, background): “Endexercise hypoxemia during maximal and submaximal steadystate exercise is a useful measure of severity in IPF (9, 10).”
• Clinical course and prediction of survival in idiopathic pulmonary fibrosis. (2011, background): “Among these features, fibroblastic foci are hypothesized to play a key role in the pathophysiology of IPF, and their profusion, as assessed by both semiquantitative and quantitative methods, has been shown, in some cohorts, to predict survival (9, 116, 117).”
• TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) (2005, background): “The number of fibroblastic foci correlates with worsening lung function, progression of IPF and a poor prognosis [2].”
• Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. (2003, background): “(6-16) Interpretation of this literature is difficult for several reasons.”